Status:
COMPLETED
Pharmacokinetics/Pharmacodynamics (PK/PD) of Multiple Oral Doses of GLPG0555 in Healthy Subjects
Lead Sponsor:
Galapagos NV
Conditions:
Healthy
Eligibility:
MALE
18-50 years
Phase:
PHASE1
Brief Summary
The purpose of the study is to evaluate the safety and tolerability of multiple ascending oral doses (MAD) of GLPG0555 given to healthy subjects for 13 days compared to placebo, and to evaluate the re...
Eligibility Criteria
Inclusion
- healthy male, age 18-50 years
- BMI between 18-30 kg/m², inclusive.
Exclusion
- significantly abnormal platelet function or coagulopathy
- smoking
- drug or alcohol abuse
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01208753
Start Date
September 1 2010
End Date
February 1 2011
Last Update
March 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SGS Stuivenberg
Antwerp, Belgium